Delivery Order SPE2DB24D2011-SPE2DB26FBPAD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,060.48 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count packages) on September 26, 2025, with a completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) valued at $1,052.59, with an ultimate completion date of August 26, 2025. This competitive, non-set-aside contract was awarded on a firm fixed-price basis under a delivery order contract type. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $1,700.00. The contract is effective through September 11, 2025, and utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.64 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) on September 5, 2025, with completion expected by September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100 count) under a firm fixed-price contract with a ceiling value of $1,103.64. The order was competitively awarded without set-aside designation and is scheduled for completion by May 12, 2025. AmerisourceBergen will fulfill this pharmaceutical delivery from its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units) under a firm fixed-price contract. The order, valued at $6,858.34, was competitively awarded without set-aside designation and is scheduled for completion by August 14, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a $1,026.24 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for OxyContin ER 10 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 23, 2025. The pharmaceutical products will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,675.65 on October 16, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract, which is not set-aside and utilizes firm fixed pricing, is scheduled for completion by October 17, 2025, with fulfillment from the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB26FBPADDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $5,071.87 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units) with an ultimate completion date of October 30, 2025. This is a firm fixed price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement and military healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor contract running through December 2026 that enables the company to supply a comprehensive range of medications, vaccines, and medical supplies globally to support military healthcare programs. The contract demonstrates AmerisourceBergen's capability to fulfill federal pharmaceutical requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/29/25 |